rhErythropoietin in Cancer Supportive Treatment

Discover cutting-edge insights into the management of anemia in cancer patients with "rhErythropoietin in Cancer Supportive Treatment," a comprehensive hardcover volume edited by leading experts R. David Gustafson and Peter D. Frisk. Published by CRC Press in 1996, this first edition, with ISBN 9780824797614, is a valuable resource for medical professionals, researchers, and students seeking a deeper understanding of the role of recombinant human erythropoietin (rhErythropoietin) in cancer therapy. This significant work stems from an international workshop, bringing together leading oncologists, hematologists, and researchers to discuss and analyze the impact of anemia on patients battling malignant diseases. The book thoroughly assesses the applications of modern molecular biology in developing innovative cancer therapies, with a particular focus on rhErythropoietin and its role in managing anemia, a common and debilitating side effect of cancer and its treatments. Explore the comprehensive summaries of the development and clinical trials of erythropoietin, meticulously presented to showcase its proven efficacy in maintaining optimal hemoglobin levels and preventing anemia caused by erythropoietin deficiency. Gain practical insights into the protocols and results of clinical trials, allowing you to stay current with the evolving standards of cancer care. Beyond the use of rhErythropoietin, "rhErythropoietin in Cancer Supportive Treatment" delves into the complex issues surrounding blood transfusions in cancer treatment. Addressing the challenges faced by blood transfusion services amidst the growing awareness of HIV and other bloodborne pathogens, the book provides a balanced perspective on the risks and benefits of blood transfusions, offering guidance for making informed decisions in patient care. While published in 1996, the foundational principles and discussions surrounding anemia management in cancer remain highly relevant. This book provides a valuable historical perspective on the development and adoption of rhErythropoietin therapy, helping readers understand the evolution of cancer supportive care practices. The insights into blood transfusion challenges are also timeless, given the ongoing need for safe and effective transfusion practices. Whether you are a seasoned oncologist, a resident in internal medicine, or a medical student specializing in oncology, "rhErythropoietin in Cancer Supportive Treatment" provides a crucial resource for your medical library. Delve into the complexities of anemia in cancer, understand the application of rhErythropoietin, and enhance your knowledge of transfusion medicine with this authoritative and insightful book. Secure your copy today and gain access to the collective wisdom of leading experts in the field of cancer supportive treatment.